Arbutus Biopharma Corp
ABUS | NASDAQ
$5
-$0.01 (-0.20%)
At close: Sep 21, 2026, 4:00 PM ET
$5
$0 (0.00%)
Pre-market:
Sep 22, 2026, 7:16 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 18.01M | 36.33M | 26.29M | 30.78M | 109.28M | 52.25M |
Short-Term Investments | 73.46M | 86.29M | 99.72M | 116.14M | 46.04M | 71.02M |
Long-Term Investments | n/a | n/a | 6.28M | 37.36M | 35.69M | n/a |
Other Long-Term Assets | 130K | 34K | n/a | 103K | 61K | 44K |
Receivables | 1.75M | 2.41M | 1.78M | 1.35M | 899K | 1.31M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.24M | 2.28M | 4.25M | 2.87M | n/a | n/a |
Total Current Assets | 94.46M | 127.32M | 132.03M | 151.14M | 160.66M | 127.7M |
Property-Plant & Equipment | 32K | 4.36M | 6.09M | 6.81M | 8.07M | 9.33M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 162K | 4.39M | 12.37M | 44.28M | 43.82M | 9.38M |
Total Assets | 94.62M | 131.71M | 144.4M | 195.42M | 204.49M | 137.08M |
Account Payables | 1.17M | 2.32M | 3.22M | 3.52M | 3.17M | 2.99M |
Deferred Revenue | n/a | 7.57M | 11.79M | 16.46M | n/a | n/a |
Short-Term Debt | 547K | 483K | n/a | 372K | 383K | n/a |
Other Current Liabilities | 2.13M | 1.86M | 3.7M | 8.78M | 3.39M | n/a |
Total Current Liabilities | 6.01M | 15.62M | 22.49M | 32.86M | 11.22M | 9.54M |
Long-Term Debt | 3.44M | 4.83M | 6.95M | 10.37M | 16.3M | 19.55M |
Other Long-Term Liabilities | 8.4M | 10.23M | 7.6M | 7.53M | 5.3M | 3.43M |
Total Long-Term Liabilities | 12.04M | 18.72M | 15.9M | 25.71M | 23.83M | 25.57M |
Total Liabilities | 18.04M | 34.34M | 38.38M | 58.57M | 35.05M | 35.11M |
Total Debt | 4.19M | 6.12M | 8.72M | 12.55M | 18.91M | 22.54M |
Book Value | 76.58M | 97.37M | 106.02M | 136.85M | 169.44M | 101.97M |
Book Value Per Share | 0.40 | 0.52 | 0.64 | 0.91 | 1.59 | 1.34 |
Common Stock | 1.42B | 1.41B | 1.35B | 1.32B | 1.29B | 985.94M |
Retained Earnings | -1.38B | -1.35B | -1.28B | -1.2B | -1.13B | -1.05B |
Comprehensive Income | -48.1M | -48.14M | -48.42M | -50.49M | -48.33M | -48.17M |
Shareholders Equity | 76.58M | 97.37M | 106.02M | 136.85M | 169.44M | 101.97M |
Total Investments | 73.46M | 86.29M | 106M | 153.5M | 81.72M | 71.02M |
Add to Watchlist
Select watchlists to add or remove ABUS